Myovant Stock Buy Hold or Sell Recommendation

MYOV -  USA Stock  

USD 20.28  0.22  1.07%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Myovant Sciences is 'Strong Sell'. Macroaxis provides Myovant Sciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MYOV positions. The advice algorithm takes into account all of Myovant Sciences' available fundamental, technical, and predictive indicators you will find on this site.

Search Advice 

The advice is provided from Myovant Sciences' buy-and-hold perspective. Additionally, see Myovant Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Myovant and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Myovant Sciences.

Execute Myovant Sciences Buy or Sell Advice

The Myovant recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Myovant Sciences. Macroaxis does not own or have any residual interests in Myovant Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Myovant Sciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Myovant SciencesBuy Myovant Sciences
Strong Sell


Not too volatileDetails

Hype Condition

Low keyDetails

Current Valuation


Odds of Distress

Very HighDetails

Economic Sensitivity

Almost neglects market trendsDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Myovant Sciences has a Mean Deviation of 2.14, Semi Deviation of 2.68, Standard Deviation of 2.71, Variance of 7.34, Downside Variance of 7.77 and Semi Variance of 7.17
Our advice module complements current analysts and expert consensus on Myovant Sciences. It analyzes the company potential to grow using all fundamental, technical, and market related data available at the time. To make sure Myovant Sciences is not overpriced, please verify all Myovant Sciences fundamentals, including its debt to equity, and the relationship between the gross profit and number of employees . Given that Myovant Sciences has a price to earning of (8.56) X, we recommend you to check Myovant Sciences market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Myovant Sciences Trading Alerts and Improvement Suggestions

Myovant Sciences has a very high chance of going through financial distress in the upcoming years
Myovant Sciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the previous year's revenue of 59.32 M. Net Loss for the year was (255.13 M) with loss before overhead, payroll, taxes, and interest of (79.36 M).
Myovant Sciences has a poor financial position based on the latest SEC disclosures
About 60.0% of the company outstanding shares are owned by corporate insiders
Latest headline from Myovant Sciences Ltd gains 2.71 percent for July 21 -

Myovant Sciences current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Myovant analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Myovant analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price36.20
Target Median Price30.00
Target High Price55.00
Recommendation Mean2.10
Number Of Analyst Opinions5
Target Low Price24.00
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Myovant Sciences Returns Distribution Density

The distribution of Myovant Sciences' historical returns is an attempt to chart the future uncertainty of Myovant Sciences' future price movements. The chart of the probability distribution of Myovant Sciences stock daily returns describes the distribution of returns around its average expected value. We use Myovant Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Myovant Sciences returns is essential to provide solid investment advice for Myovant Sciences stock.
Mean Return0.11Value At Risk-4.01
Potential Upside4.18Standard Deviation2.71
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Myovant Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Myovant Sciences Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Myovant Sciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Myovant Sciences stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Myovant stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW-0.27
Overall volatility
Information ratio 0.0194

Myovant Sciences Volatility Alert

Myovant Sciences currently demonstrates below-average downside deviation. It has Information Ratio of 0.02 and Jensen Alpha of 0.12. However, we advise investors to further question Myovant Sciences expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Myovant Sciences' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Myovant Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Myovant Sciences Fundamentals Vs Peers

Comparing Myovant Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Myovant Sciences' direct or indirect competition across all of the common fundamentals between Myovant Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Myovant Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Myovant Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Myovant Sciences by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Myovant Sciences to competition
FundamentalsMyovant SciencesPeer Average
Return On Equity20.67 %(0.31) %
Return On Asset(35.36) %(0.14) %
Operating Margin(396.32) %(5.51) %
Current Valuation1.66 B16.62 B
Shares Outstanding91.48 M571.82 M
Shares Owned by Insiders60.22 %10.09 %
Shares Owned by Institutions38.55 %39.21 %
Number of Shares Shorted3.03 M4.71 M
Price to Earning(8.56) X28.72 X
Price to Book6.43 X9.51 X
Price to Sales30.69 X11.42 X
Revenue59.32 M9.43 B
Gross Profit(79.36 M)27.38 B
EBITDA(232.6 M)3.9 B
Net Income(255.13 M)570.98 M
Cash and Equivalents684.93 M2.7 B
Cash per Share7.49 X5.01 X
Total Debt369.7 M5.32 B
Debt to Equity138.60 %48.70 %
Current Ratio2.51 X2.16 X
Book Value Per Share(3.89) X1.93 K
Cash Flow from Operations370.63 M971.22 M
Short Ratio4.19 X4.00 X
Earnings Per Share(2.83) X3.12 X
Number of Employees40718.84 K
Market Capitalization1.82 B19.03 B
Total Asset151.84 M29.47 B
Retained Earnings(811.83 M)9.33 B
Working Capital123.03 M1.48 B
Current Asset150.17 M9.34 B
Current Liabilities27.14 M7.9 B
Z Score-7.98.72
   Sale by Matthew Lang of 6954 shares of Myovant Sciences [view details]

Myovant Sciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Myovant . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution23622.24
Daily Balance Of Power(0.31)
Rate Of Daily Change0.99
Day Median Price20.13
Day Typical Price20.18
Market Facilitation Index0.0
Price Action Indicator0.035

About Myovant Sciences Buy or Sell Advice

When is the right time to buy or sell Myovant Sciences? Buying financial instruments such as Myovant Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Myovant Sciences investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2018 2019 2020 2021 (projected)
Current Assets166.79 M87.91 M704.64 M760.27 M
Total Assets172.98 M105.93 M725.03 M782.27 M

Use Investing Ideas to Build Portfolios

In addition to having Myovant Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Healthcare theme has 56 constituents.
View All  Next Launch Healthcare
Additionally, see Myovant Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
CEO Directory
Screen CEOs from public companies around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.